-
1
-
-
0036145366
-
Patients with Fabry disease on dialysis in the United States
-
Thadhoni R, Wolf M, West ML, et al. Patients with Fabry disease on dialysis in the United States. Kidney Int 2002; 61: 249-55.
-
(2002)
Kidney Int
, vol.61
, pp. 249-255
-
-
Thadhoni, R.1
Wolf, M.2
West, M.L.3
-
2
-
-
0036122659
-
Natural history of Fabry renal disease: Influence of alpha-galactosidase a activity and genetic mutations on clinical course
-
Branton MH, Schiffmann R, Sabnis SG, et al. Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course. Medicine (Baltimore) 2002; 81: 122-38.
-
(2002)
Medicine (Baltimore)
, vol.81
, pp. 122-138
-
-
Branton, M.H.1
Schiffmann, R.2
Sabnis, S.G.3
-
3
-
-
0017872842
-
Early renal changes in hemizygous and heterozygous patients with Fabry's disease
-
Gubler MC, Lenoir G, Grünfeld JP, et al. Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int 1978; 13: 223-35.
-
(1978)
Kidney Int
, vol.13
, pp. 223-235
-
-
Gubler, M.C.1
Lenoir, G.2
Grünfeld, J.P.3
-
4
-
-
0016802543
-
La transplantation rénale chez les sujets atteints de maladie de Fabry
-
Grünfeld JP, Le Porrier M, Droz D, et al. La transplantation rénale chez les sujets atteints de maladie de Fabry. Nouv Presse Med 1975; 29: 2081-5.
-
(1975)
Nouv Presse Med
, vol.29
, pp. 2081-2085
-
-
Grünfeld, J.P.1
Le Porrier, M.2
Droz, D.3
-
5
-
-
0034660663
-
Excellent outcome of renal transplantation in patients with Fabry's disease
-
Ojo A, Meier-Kriesche HU, Friedman G, et al. Excellent outcome of renal transplantation in patients with Fabry's disease. Transplantation 2000; 69: 2337-9.
-
(2000)
Transplantation
, vol.69
, pp. 2337-2339
-
-
Ojo, A.1
Meier-Kriesche, H.U.2
Friedman, G.3
-
6
-
-
0036436320
-
Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy
-
t. Thurberg BL, Rennke H, Robert B, et al. Globotriaosylceramide accumulation in the Fabry kidney is cleared from multiple cell types after enzyme replacement therapy. Kidney Int 2002; 62: 1933-46.
-
(2002)
Kidney Int
, vol.62
, pp. 1933-1946
-
-
Thurberg, B.L.1
Rennke, H.2
Robert, B.3
-
7
-
-
3142554529
-
Long-term safty and efficacy on enzyme replacement therapy for Fabry disease
-
Wilcox WR, Banikazemi M, Guffon N, et al. Long-term safty and efficacy on enzyme replacement therapy for Fabry disease. Am J Hum Genet 2004; 75: 65-74.
-
(2004)
Am J Hum Genet
, vol.75
, pp. 65-74
-
-
Wilcox, W.R.1
Banikazemi, M.2
Guffon, N.3
-
8
-
-
0037237933
-
Enzyme replacement therapy in Anderson-Fabry's disease: Beneficial clinical effect on vital organ function
-
De Schoenmakere G, Chauveau D, Grünfeld JP. Enzyme replacement therapy in Anderson-Fabry's disease: beneficial clinical effect on vital organ function. Nephrol Dial Transplant 2003; 18: 33-5.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 33-35
-
-
De Schoenmakere, G.1
Chauveau, D.2
Grünfeld, J.P.3
-
9
-
-
4344671895
-
Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease
-
Kosch M, Koch HG, Oliveira JP, et al. Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease. Kidney Int 2004; 66: 1279-82.
-
(2004)
Kidney Int
, vol.66
, pp. 1279-1282
-
-
Kosch, M.1
Koch, H.G.2
Oliveira, J.P.3
-
10
-
-
1642463470
-
Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: A pilot study
-
Mignani R, Panichi V, Giudicissi A, et al. Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study. Kidney Int 2004; 65: 1381-5.
-
(2004)
Kidney Int
, vol.65
, pp. 1381-1385
-
-
Mignani, R.1
Panichi, V.2
Giudicissi, A.3
|